CPRX Financial Facts

Total operating costs and expenses: 3.91M
Net loss: -3.95M
See Full Income Statement

Accrued expenses and other liabilities: 940.27K
Total liabilities and stockholders' equity: 45.31M
See Full Balance Sheet

Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings

  |   Expand Research on CPRX
Next EPS Date 3/15/17 *Est. EPS Growth Rate 0.0% *Last Qtr.
Average EPS % Beat Rate +10.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +4.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/16 Q316 -$0.05-$0.06 +$0.01N/AN/A N/A Details
8/9/16 Q216 -$0.06-$0.08 +$0.02N/AN/A N/A Details
5/10/16 Q116 -$0.07-$0.07 $0.00N/AN/A N/A Details
3/15/16 Q415 -$0.07-$0.07 $0.00N/AN/A N/A Details
11/9/15 Q315 -$0.05-$0.07 +$0.02N/AN/A N/A Details
8/10/15 Q215 -$0.06-$0.08 +$0.02N/AN/A N/A Details
5/11/15 Q115 -$0.07-$0.09 +$0.02N/AN/A N/A Details
3/16/15 Q414 -$0.06-$0.07 +$0.01N/AN/A N/A Details